Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: A randomised, double‐blind, placebo‐controlled trial.

MLA

Nabatian, Asl, Mohammadmahdi, et al. “Effects of Melatonin Supplementation on Serum Oxidative Stress Markers and Disease Activity in Systemic Lupus Erythematosus Patients: A Randomised, Double‐blind, Placebo‐controlled Trial.” International Journal of Clinical Practice, vol. 75, no. 7, July 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1111/ijcp.14246.

APA

Nabatian, A. M., Ghorbanihaghjo, A., Malek Mahdavi, A., Khabbazi, A., Hajialilo, M., & Ghojazadeh, M. (2021). Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: A randomised, double‐blind, placebo‐controlled trial. International Journal of Clinical Practice, 75(7), 1–9. https://doi.org/10.1111/ijcp.14246

Chicago

Nabatian, Asl, Mohammadmahdi, Amir Ghorbanihaghjo, Aida Malek Mahdavi, Alireza Khabbazi, Mehrzad Hajialilo, and Morteza Ghojazadeh. 2021. “Effects of Melatonin Supplementation on Serum Oxidative Stress Markers and Disease Activity in Systemic Lupus Erythematosus Patients: A Randomised, Double‐blind, Placebo‐controlled Trial.” International Journal of Clinical Practice 75 (7): 1–9. doi:10.1111/ijcp.14246.